Skip to content
medical devices and technologies hero image
medical devices and technologies hero image

Medical Devices and Technologies

Our global medical devices and technologies group acts for companies and institutions across the sector and provides advice to ensure that clients are well placed to manage the challenges they face to capitalise on opportunities

Our global medical devices and technologies group acts for companies and institutions across the sector and provides advice to ensure that clients are well placed to manage the challenges they face to capitalise on opportunities.

Our team spans disciplines including intellectual property (contentious and non-contentious), regulatory, product liability, mergers and acquisitions, commercial transactions (including licensing and collaborations), and capital markets and finance matters.

Our international network ensures that we have a ready resource of expertise in a wide range of jurisdictions and that we are well positioned to advise on cross-border work. Our lawyers have been advising clients in the sector for many years and have developed a deep understanding of the issues affecting the industry. This ensures that we add value to any matter and there is no learning curve.

For example, our team has been closely following the current proposed changes to the European medical devices regulatory framework. We have also been tracking and advising our clients on regulatory issues in the context of emerging technologies such as device/drug combinations, medical apps and other “connected health” initiatives. In these areas we use our broad and interdisciplinary experience to help our clients navigate what may often be rapidly evolving or uncertain regulatory pathways and manage the risks of new product development.

Our clients in the medical devices sector include Biomet, Samsung, GE Healthcare, Johnson & Johnson, Fresenius, Covidien, St Jude Medical and Novartis.

News & Insights

Impfdosen

Publications: 03 MARCH 2021

#Employmenttalk: Impfen

Nach sieben Ausgaben unserer Client Call-Serie rund um das Themengebiet Covid-19 möchten wir nun auf das Thema Impfen im Detail eingehen.

Lesen Sie mehr
Online Gesundheitsportal

News: 11 FEBRUARY 2021

Allen & Overy begleitet Tochter der französischen Fernsehsendergruppe TF1 bei Verkauf von Gesundheitsportal Onmeda.de an FUNKE Medien

Allen & Overy hat die zur französischen Medienholding Groupe TF1 und deren Segment Unify gehörende gofeminin.de GmbH aus Köln beim Verkauf des Gesundheitsportals Onmeda.de an die FUNKE Mediengruppe…

Lesen Sie mehr
Covid-19

Publications: 26 MARCH 2020

Covid-19 Coronavirus: Änderung des Infektionsschutzgesetzes des Bundes

Nachdem die bayerische Staatsregierung bereits letzte Woche Pläne verlauten ließ, ein bayerisches Infektionsschutzgesetz zu erlassen, das ausreichende Grundlagen schaffen sollte, um im Notfall die…

Lesen Sie mehr

Download our sector brochure

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.